Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: A cross-sectional, multisite, epidemiological study protocol

BMJ Open

Volumn 4, Issue 6, 2014, Pages

  Tan, Edwin C K ^a   Visvanathan, Renuka ^b,c   Hilmer, Sarah N ^d,e   Vitry, Agnes I ^f   Quirke, Tara ^g   Emery, Tina ^h   Robson, Leonie ^h   Shortt, Terry ^h   Sheldrick, Simon ^h   Lee, Sunny ^h   Clothier, Robyn ^c,h   Reeve, Emily ^d,e   Gnjidic, Danijela ^d   Ilomäki, Jenni ^a   Bell, J Simon ^a,e,f,i  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e HORNSBY KU RING GAI HOSPITAL   (Australia)

^f UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^g Consumer Dementia Research Network Alzheimer's Australia ^*  (Australia)

^h Resthaven Incorporated   (Australia)

ⁱ UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; HYPNOTIC SEDATIVE AGENT;

ADULT; ARTICLE; AUSTRALIA; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DEMENTIA; FEMALE; GERIATRIC CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; NURSE; NUTRITIONAL STATUS; PAIN; PATIENT SATISFACTION; PRESCRIPTION; QUALITY OF LIFE; RESIDENT; SEDATION; AGED; ANALGESIA; CLINICAL TRIAL; COMPLICATION; HOME FOR THE AGED; METHODOLOGY; MULTICENTER STUDY; PROCEDURES;

AGED; ANALGESICS; CROSS-SECTIONAL STUDIES; DEMENTIA; HOMES FOR THE AGED; HUMANS; HYPNOTICS AND SEDATIVES; PAIN; PAIN MANAGEMENT; RESEARCH DESIGN;

EID: 84903194488     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005757     Document Type: Article

References (51)

1. Herr K. Pain assessment strategies in older patients. J Pain 2011;12:S3-13.
2. Piazza Research and Alzheimer's Australia. End of life care for people with dementia. Canberra: Alzheimer 's Australia, 2014.
3. Scherder E, Herr K, Pickering G, et al. Pain in dementia. Pain 2009;145:276-8.
4. Scherder EJ, Bouma A. Is decreased use of analgesics in Alzheimer disease due to a change in the affective component of pain? Alzheimer Dis Assoc Disord 1997;11:171-4. (Pubitemid 27406253)
5. Schmader KE, Hanlon JT, Fillenbaum GG, et al. Medication use patterns among demented, cognitively impaired and cognitively intact community-dwelling elderly people. Age Ageing 1998;27:493-501. (Pubitemid 28404614)
6. Tan ECK, Jokanovic N, Koponen MP, et al. Analgesic use and pain in people with and without dementia or cognitive impairment in aged care facilities: a systematic review and meta-analysis. Curr Clin Pharmacol 2014; in press.
7. Kunik ME, Cully JA, Snow AL, et al. Treatable comorbid conditions and use of VA health care services among patients with dementia. Psychiatr Serv 2005;56:70-5. (Pubitemid 40094473)
8. Kunik ME, Snow AL, Davila JA, et al. Causes of aggressive behavior in patients with dementia. J Clin Psychiatry 2010;71:1145-52.
9. Cordner Z, Blass DM, Rabins PV, et al. Quality of life in nursing home residents with advanced dementia. J Am Geriatr Soc 2010;58:2394-400.
10. Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009;8:151-7.
11. Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 2007;62:1172-81. (Pubitemid 47599431)
12. Mitchell SJ, Hilmer SN, McLachlan AJ. Clinical pharmacology of analgesics in old age and frailty. Rev Clin Gerontol 2009;19:103-18.
13. McLachlan AJ, Hilmer SN, Le Couteur DG. Variability in response to medicines in older people: phenotypic and genotypic factors. Clin Pharmacol Ther 2009;85:431-3.
14. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009;85:86-8.
15. Bell JS, Laitinen ML, Lavikainen P, et al . Use of strong opioids among community-dwelling persons with and without Alzheimer's disease in Finland. Pain 2011;152:543-7.
16. Murnion BP, Gnjidic D, Hilmer SN. Prescription and administration of opioids to hospital in-patients, and barriers to effective use. Pain Med 2010;11:58-66.
17. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-43. (Pubitemid 41464695)
18. Husebo BS, Ballard C, Sandvik R, et al. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ 2011;343:d4065.
19. Pautex S, Michon A, Guedira M, et al. Pain in severe dementia: self-assessment or observational scales? J Am Geriatr Soc 2006;54:1040-5. (Pubitemid 43992539)
20. Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc 2003;4:9-15. (Pubitemid 36163632)
21. International Association for the Study of Pain. Faces Pain Scale - Revised. 2012. http://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1519
22. The Anatomical Therapeutic Chemical Classification System. http://www.whocc.no/atc-ddd-index/
23. Sloane P, Ivey J, Roth M, et al. Accounting for the sedative and analgesic effects of medication changes during patient participation in clinical research studies: measurement development and application to a sample of institutionalized geriatric patients. Contemp Clin Trials 2008;29:140-8. (Pubitemid 351248761)
24. Taipale HT, Bell JS, Soini H, et al. Sedative load and mortality among residents of long-term care facilities: a prospective cohort study. Drugs Aging 2009;26:871-81.
25. Pasero C, McCaffery M. Monitoring sedation. Am J Nurs 2002;102:67-9.
26. Nisbet AT, Mooney-Cotter F. Comparison of selected sedation scales for reporting opioid-induced sedation assessment. Pain Manag Nurs 2009;10:154-64.
27. Lee JH, Bliwise DL, Ansari FP, et al. Daytime sleepiness and functional impairment in Alzheimer disease. Am J Geriatr Psychiatry 2007;15:620-6.
28. O'Suilleabhain PE, Dewey RB Jr. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol 2002;59:986-9. (Pubitemid 34640759)
29. Latimer Hill E, Cumming RG, Lewis R, et al. Sleep disturbances and falls in older people. J Gerontol A Biol Sci Med Sci 2007;62:62-6. (Pubitemid 46931548)
30. St George RJ, Delbaere K, Williams P, et al. Sleep quality and falls in older people living in self- and assisted-care villages. Gerontology 2009;55:162-8.
31. Clark CM, Ewbank DC. Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer disease. Alzheimer Dis Assoc Disord 1996;10:31-9. (Pubitemid 26073890)
32. Wood S, Cummings JL, Hsu MA, et al. The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry 2000;8:75-83. (Pubitemid 30036844)
33. Cummings JL, Mega M, Gray K, et al. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-14. (Pubitemid 24382728)
34. Edelman P, Fulton BR, Kuhn D, et al. A comparison of three methods of measuring dementia-specific quality of life: perspectives of residents, staff, and observers. Gerontologist 2005;45(Spec No 1):27-36. (Pubitemid 41606920)
35. Logsdon RG, Gibbons LE, McCurry SM, et al. Assessing quality of life in older adults with cognitive impairment. Psychosom Med 2002;64:510-19. (Pubitemid 34556417)
36. Beer C, Flicker L, Horner B, et al. Factors associated with self and informant ratings of the quality of life of people with dementia living in care facilities: a cross sectional study. PLoS ONE 2010;5:e15621.
37. Reeve E, Shakib S, Hendrix I, et al. Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm 2013;35:51-6.
38. Dementia Outcomes Measurement Suite. http://www.dementia-assessment.com. au/symptoms/
39. Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002;18:737-57. (Pubitemid 35239179)
40. Kaiser MJ, Bauer JM, Ramsch C, et al. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging 2009;13:782-8.
41. Jyrkka J, Mursu J, Enlund H, et al. Polypharmacy and nutritional status in elderly people. Curr Opin Clin Nutr Metab Care 2012;15:1-6.
42. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-19.
43. Groll DL, To T, Bombardier C, et al. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005;58:595-602. (Pubitemid 40692725)
44. Lau DT, Kasper JD, Potter DE, et al. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005;165:68-74. (Pubitemid 40096084)
45. Somers M, Rose E, Simmonds D, et al . Quality use of medicines in residential aged care. Aust Fam Physician 2010;39:413-16.
46. Stafford AC, Alswayan MS, Tenni PC. Inappropriate prescribing in older residents of Australian care homes. J Clin Pharm Ther 2011;36:33-44.
47. Karttunen K, Karppi P, Hiltunen A, et al . Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease. Int J Geriatr Psychiatry 2011;26:473-82.
48. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690-1. (Pubitemid 28532993)
49. Janssen KJ, Donders AR, Harrell FE Jr, et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol 2010;63:721-7.
50. Gnjidic D, Hilmer SN, Blyth FM, et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther 2012;91:521-8.
51. National Statement for Ethical Conduct in Human Research. http://www.nhmrc.gov.au/-files-nhmrc/publications/attachments/ e72-national-statement-march-2014-140331.pdf